{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:49:48Z","timestamp":1777657788908,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP111129"],"award-info":[{"award-number":["MOP111129"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44NS120541-01"],"award-info":[{"award-number":["R44NS120541-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0252"],"award-info":[{"award-number":["W81XWH-15-1-0252"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.lfs.2022.120788","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T23:45:13Z","timestamp":1657323913000},"page":"120788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103"],"prefix":"10.1016","volume":"306","author":[{"given":"Michael R.","family":"Ruff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadet","family":"Inan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Qun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Meissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby K.","family":"Eisenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120788_bb0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mi.9.4.7","article-title":"Chemokine signaling and the management of neuropathic pain","volume":"9","author":"White","year":"2009","journal-title":"Mol. Interv."},{"key":"10.1016\/j.lfs.2022.120788_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615327","article-title":"Bidirectional action of cenicriviroc, a CCR2\/CCR5 antagonist, results in alleviation of pain-related behaviors and potentiation of opioid analgesia in rats with peripheral neuropathy","volume":"11","author":"Kwiatkowski","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.120788_bb0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2011.09.022","article-title":"Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation","volume":"153","author":"Padi","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.198","article-title":"CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury","volume":"4","author":"Akimoto","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2022.120788_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.intimp.2017.09.021","article-title":"Spinal CCL1\/CCR8 signaling interplay as a potential therapeutic target - evidence from a mouse diabetic neuropathy model","volume":"52","author":"Zychowska","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2022.120788_bb0030","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/j.pain.0000000000001212","article-title":"Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity","volume":"159","author":"Illias","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuroscience.2007.08.014","article-title":"Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses","volume":"149","author":"Menetski","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2022.120788_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1744-8069-6-90","article-title":"Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain","volume":"6","author":"Serrano","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/AJP.0000000000000319","article-title":"Involvement of CCL3\/CCR5 signaling in dorsal root ganglion in remifentanil-induced hyperalgesia in rats","volume":"32","author":"Li","year":"2016","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0050","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s12035-018-1176-8","article-title":"The chemokine CCL4 (MIP-1beta) evokes antinociceptive effects in mice: a role for CD4(+) lymphocytes and met-enkephalin","volume":"56","author":"Garcia-Dominguez","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2022.120788_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2008.07.009","article-title":"Elevated level of the proinflammatory chemokine, RANTES\/CCL5, in the periaqueductal grey causes hyperalgesia in rats","volume":"592","author":"Benamar","year":"2008","journal-title":"Eur.J.Pharmacol."},{"key":"10.1016\/j.lfs.2022.120788_bb0060","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1073\/pnas.102327699","article-title":"Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain","volume":"99","author":"Szabo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.120788_bb0065","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health (NSDUH)","author":"BJ","year":"2017"},{"key":"10.1016\/j.lfs.2022.120788_bb0070","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1526-4637.2009.00655.x","article-title":"The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population","volume":"10","author":"Toth","year":"2009","journal-title":"Pain Med."},{"key":"10.1016\/j.lfs.2022.120788_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/AJP.0000000000000124","article-title":"Opioid use in the management of diabetic peripheral neuropathy (DPN) in a large commercially insured population","volume":"31","author":"Patil","year":"2015","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0080","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.clinthera.2018.04.001","article-title":"Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy","volume":"40","author":"Iqbal","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2022.120788_bb0085","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/00002030-199907090-00015","article-title":"Changes to AIDS dementia complex in the era of highly active antiretroviral therapy","volume":"13","author":"Dore","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.lfs.2022.120788_bb0090","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ALN.0000000000002238","article-title":"Persistent postsurgical pain: pathophysiology and preventative pharmacologic considerations","volume":"129","author":"Richebe","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.lfs.2022.120788_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1570162033352066","article-title":"Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors","volume":"1","author":"Ruff","year":"2003","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.lfs.2022.120788_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuint.2017.12.005","article-title":"Neuropathic pain inhibitor, RAP-103, is a potent inhibitor of microglial CCL1\/CCR8","volume":"119","author":"Noda","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2022.120788_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0110","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7898.1","article-title":"Updates in diabetic peripheral neuropathy","volume":"5","author":"Juster-Switlyk","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.lfs.2022.120788_bb0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/jpet.118.252890","article-title":"Coadministration of chemokine receptor antagonists with morphine potentiates Morphine's analgesic effect on incisional pain in rats","volume":"367","author":"Inan","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2022.120788_bb0120","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/j.bja.2019.01.021","article-title":"Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats","volume":"122","author":"Inan","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.lfs.2022.120788_bb0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0304-3959(95)01441-1","article-title":"Characterization of a rat model of incisional pain","volume":"64","author":"Brennan","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J.Neurosci.Methods."},{"key":"10.1016\/j.lfs.2022.120788_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2022.120788_bb0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2022.120788_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1073858403259950","article-title":"Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance\/hyperalgesia","volume":"10","author":"DeLeo","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.lfs.2022.120788_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.sjpain.2017.08.002","article-title":"Targeting cytokines for treatment of neuropathic pain","volume":"17","author":"Hung","year":"2017","journal-title":"Scand. J. Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112296","article-title":"Pharmacological regulation of neuropathic pain driven by inflammatory macrophages","volume":"18","author":"Kiguchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120788_bb0165","article-title":"Stat3 inhibition attenuates mechanical allodynia through transcriptional regulation of chemokine expression in spinal astrocytes","volume":"8","author":"Liu","year":"2013","journal-title":"PloS one."},{"key":"10.1016\/j.lfs.2022.120788_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","article-title":"Role of interleukin-1beta during pain and inflammation","volume":"60","author":"Ren","year":"2009","journal-title":"Brain Res.Rev."},{"key":"10.1016\/j.lfs.2022.120788_bb0175","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1213\/01.ane.0000275190.42912.37","article-title":"Pathophysiology of peripheral neuropathic pain: immune cells and molecules","volume":"105","author":"Thacker","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.lfs.2022.120788_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/sjpain-2019-0138","article-title":"Role of the immune system in neuropathic pain","volume":"20","author":"Malcangio","year":"2019","journal-title":"Scand J Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0185","doi-asserted-by":"crossref","first-page":"20151","DOI":"10.1073\/pnas.0709250104","article-title":"Chemokines and the pathophysiology of neuropathic pain","volume":"104","author":"White","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.120788_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2009.07.012","article-title":"Opiate-induced hypernociception and chemokine receptors","volume":"58","author":"White","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2022.120788_bb0195","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd1852","article-title":"Chemokines: integrators of pain and inflammation","volume":"4","author":"White","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2022.120788_bb0200","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugalcdep.2006.09.010","article-title":"Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats","volume":"88","author":"Chen","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.lfs.2022.120788_bb0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.188.2.317","article-title":"Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization","volume":"188","author":"Grimm","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2022.120788_bb0210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.173.1.594","article-title":"Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons","volume":"173","author":"Zhang","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.120788_bb0215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbi.2010.10.020","article-title":"Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey","volume":"25","author":"Heinisch","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2022.120788_bb0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2017.01.014","article-title":"Hyperalgesic and hypoalgesic mechanisms evoked by the acute administration of CCL5 in mice","volume":"62","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.lfs.2022.120788_bb0225","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11064-016-2108-5","article-title":"Involvement of spinal CCR5\/PKC\u03b3 signaling pathway in the maintenance of cancer-induced bone pain","volume":"42","author":"Hang","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.120788_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2012.10.030","article-title":"Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli","volume":"67","author":"Lee","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2022.120788_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainresbull.2017.10.009","article-title":"Chemokine CCL8 and its receptor CCR5 in the spinal cord are involved in visceral pain induced by experimental colitis in mice","volume":"135","author":"Lu","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2022.120788_bb0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroscience.2013.11.055","article-title":"The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells","volume":"259","author":"Pevida","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2022.120788_bb0245","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/j.1532-2149.2012.00146.x","article-title":"CC-chemokine ligand 4\/macrophage inflammatory protein-1beta participates in the induction of neuropathic pain after peripheral nerve injury","volume":"16","author":"Saika","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0250","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14656566.2019.1583743","article-title":"State of the art opioid-sparing strategies for post-operative pain in adult surgical patients","volume":"20","author":"Gabriel","year":"2019","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.lfs.2022.120788_bb0255","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1111\/bph.14769","article-title":"Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB1 and CB2 receptors","volume":"176","author":"Chen","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120788_bb0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1399-6576.2000.440112.x","article-title":"Pre-incisional epidural ketamine, morphine and bupivacaine combined with epidural and general anaesthesia provides pre-emptive analgesia for upper abdominal surgery","volume":"44","author":"Wu","year":"2000","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"1143\u201357","key":"10.1016\/j.lfs.2022.120788_bb0265","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2022.120788_bb0270","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.celrep.2018.01.006","article-title":"Mechanistic differences in neuropathic pain modalities revealed by correlating behavior with global expression profiling","volume":"22","author":"Cobos","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2022.120788_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2012.08.012","article-title":"Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of toll-like receptor 4 expression","volume":"526","author":"Yan","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.lfs.2022.120788_bb0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pain.2010.02.025","article-title":"Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation","volume":"149","author":"Kiguchi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2022.120788_bb0285","doi-asserted-by":"crossref","first-page":"12396","DOI":"10.1523\/JNEUROSCI.3016-07.2007","article-title":"Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2022.120788_bb0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.07.005","article-title":"Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats","volume":"64","author":"Kwiatkowski","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2022.120788_bb0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5055\/jom.2006.0041","article-title":"Significant pain reduction in chronic pain patients after detoxification from high-dose opioids","volume":"2","author":"Baron","year":"2006","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.lfs.2022.120788_bb0300","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain-misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200488X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200488X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:59:51Z","timestamp":1758401991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052200488X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":60,"alternative-id":["S002432052200488X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120788","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120788"}}